Symposium

[S36] Current status and prospects for mRNA vaccines

Mon. Mar 27, 2023 9:00 AM - 11:00 AM [Room M1] The Alumni Hall "Frate": Hall (1F)

Organizer: Yasuo Yoshioka, Jun Kunisawa

The SARS-CoV-2 pandemic has accelerated vaccine development at an unprecedented rate. Especially, mRNA vaccines provide highly effective protection and have been widely used. In this symposium, we will discuss current status and prospects for mRNA vaccines.

+Add all to schedule

9:00 AM - 9:25 AM

[S36-01] Considerations for quality assessment of mRNA vaccines

○Takao Inoue¹ (1. NIHS)

9:25 AM - 9:40 AM

[S36-02] Development of mRNA vaccine for influenza

○Yasuo Yoshioka^1,2 (1. RIMD/OTRI/Pharm. Sci/CiDER/CAMaD/MEI, Osaka Univ., 2. BIKEN)

9:40 AM - 10:05 AM

[S36-03] Cytosolic RNA-sensing machinery contributes the immunogenicity and reactogenicity of LNP-mRNA vaccine targeting SARS-CoV-2 receptor-binding domain

○Kouji Kobiyama^1,2 (1. IMSUT, 2. vDesC, IMSUT)

10:05 AM - 10:35 AM

[S36-04] Development of translation control technology by mRNA design

○Hirohide Saito¹ (1. Kyoto Univ. CiRA)

10:35 AM - 10:55 AM

[S36-05] Possible application of functional lipids for the development of vaccine carriers and adjuvants

○Jun Kunisawa^1,2,3,4,5,6 (1. NIBIOHN, 2. Osaka Univ, 3. IMSUT, 4. Kobe Univ, 5. Hiroshima Univ, 6. Waseda Univ)

まとめ：國澤純（医薬健栄研） (10:55 AM - 11:00 AM)

Session information